Novo Nordisk Settles Over US Federal Investigation Of Marketing Practices

06 Sep 2017

• By Sten Stovall

Novo Nordisk has settled with the US Federal government over claims it did not comply with communicating safety information on its diabetes drug Victoza.

Gavel — Novo Nordisk Pays $58.7m to resolve US Justice Department Victoza probe • Source: Shutterstock

Novo Nordisk Settles Over US Federal Investigation Of Marketing Practices

More from Legal & IP

More from Business